Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Apr 24, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $17.26
Apr 24, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $18.11
Apr 24, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Other acquisition or disposition -- --
Apr 24, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $17.26
Apr 19, 2018
Director
Director Other acquisition or disposition -- --
Apr 19, 2018
Director
Director Other acquisition or disposition -- --
Apr 19, 2018
Director
Director Other acquisition or disposition -- --
Apr 19, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $18.67
Apr 19, 2018
Director
Director Other acquisition or disposition -- --
Apr 19, 2018
Director
Director Other acquisition or disposition -- --
Apr 19, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $18.37
Apr 19, 2018
Director
Director Other acquisition or disposition -- --
Apr 19, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $19.18
Apr 17, 2018
Director, CEO & President
Director, CEO & President Open market or private sale of non-derivative or derivative security 11,565 $19.00
Apr 16, 2018
EVP, COO & CCO
EVP, COO & CCO Other acquisition or disposition -- --
Apr 16, 2018
EVP, COO & CCO
EVP, COO & CCO Open market or private sale of non-derivative or derivative security 1,840 $19.07
Apr 16, 2018
EVP, COO & CCO
EVP, COO & CCO Open market or private sale of non-derivative or derivative security 3,900 $18.59
Apr 16, 2018
Director
Director Other acquisition or disposition -- --
Apr 16, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $19.71
Apr 16, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $18.56

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.